| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-05 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |